Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
出版年份 2017 全文链接
标题
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
作者
关键词
Osteosarcoma, KP46, Anticancer gallium compound, Autophagy, Obatoclax
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-12
DOI
10.1186/s13046-017-0527-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Future directions in the treatment of osteosarcoma
- (2016) Michael W. Bishop et al. CURRENT OPINION IN PEDIATRICS
- Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro
- (2016) M. A. Hoda et al. MOLECULAR CANCER THERAPEUTICS
- Update on Survival in Osteosarcoma
- (2016) Megan E. Anderson ORTHOPEDIC CLINICS OF NORTH AMERICA
- Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis
- (2016) Dávid Kovács et al. Scientific Reports
- The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo
- (2015) Rita Dornetshuber-Fleiss et al. BIOCHEMICAL PHARMACOLOGY
- Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling
- (2015) Bruno Christian Koehler et al. BMC CANCER
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
- (2015) Michael S. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
- (2015) Florian Sevelda et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin
- (2015) Xu-Dong Miao et al. Asian Pacific Journal of Tropical Medicine
- Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
- (2014) U. Jungwirth et al. MOLECULAR CANCER THERAPEUTICS
- Integrin inhibition promotes atypical anoikis in glioma cells
- (2014) M Silginer et al. Cell Death & Disease
- Autophagy modulates cell migration and β1 integrin membrane recycling
- (2013) Véronique Tuloup-Minguez et al. CELL CYCLE
- Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair
- (2013) K. Kryeziu et al. MOLECULAR CANCER THERAPEUTICS
- p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade
- (2013) Yong Ding et al. TUMOR BIOLOGY
- Regulation of Cell Adhesion and Migration by Kindlin-3 Cleavage by Calpain
- (2012) Yongzhong Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gallium compound GaQ3-induced Ca2+ signalling triggers p53-dependent and -independent apoptosis in cancer cells
- (2011) Rajan Gogna et al. BRITISH JOURNAL OF PHARMACOLOGY
- Calpains promote α2β1 integrin turnover in nonrecycling integrin pathway
- (2011) Nina Rintanen et al. MOLECULAR BIOLOGY OF THE CELL
- Functional and biological analysis of Bcl-xL expression in human osteosarcoma
- (2010) Zhao-Xia Wang et al. BONE
- Prognostic markers in osteosarcoma
- (2010) Sameer Bakhshi et al. Expert Review of Anticancer Therapy
- The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines
- (2009) Seied Mojtaba Valiahdi et al. MELANOMA RESEARCH
- Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects
- (2009) Andrei R. Timerbaev Metallomics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now